Specification
Description
MUN36378 is a FTO inhibitor for treatment of leukemia. This compound was first reported in patent WO 2018157842.
Synonyms
MUN36378; MUN-36378; MUN 36378
IUPAC Name
2-[[2,6-Dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]benzoic acid
Canonical SMILES
O=C(O)C1=CC=CC=C1NC2=C(Cl)C=C(C3=C(C)NN=C3C)C=C2Cl
InChI
InChI=1S/C18H15Cl2N3O2/c1-9-16(10(2)23-22-9)11-7-13(19)17(14(20)8-11)21-15-6-4-3-5-12(15)18(24)25/h3-8,21H,1-2H3,(H,22,23)(H,24,25)
InChI Key
MCENODSHXUWMEL-UHFFFAOYSA-N
Solubility
To be determined
Shelf Life
>2 years if stored properly
Storage
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Drug Formulation
To be determined
Elemental Analysis
C, 57.46; H, 4.02; Cl, 18.84; N, 11.17; O, 8.50
HS Tariff Code
2934.99.9001
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).